133 related articles for article (PubMed ID: 15138557)
21. Increased expression of 5-lipoxygenase in high-grade astrocytomas.
Nathoo N; Prayson RA; Bondar J; Vargo L; Arrigain S; Mascha EJ; Suh JH; Barnett GH; Golubic M
Neurosurgery; 2006 Feb; 58(2):347-54; discussion 347-54. PubMed ID: 16462489
[TBL] [Abstract][Full Text] [Related]
22. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.
Said HM; Stein S; Hagemann C; Polat B; Staab A; Anacker J; Schoemig B; Theobald M; Flentje M; Vordermark D
Oncol Rep; 2009 Jan; 21(1):237-46. PubMed ID: 19082468
[TBL] [Abstract][Full Text] [Related]
23. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules.
Liu X; Chen N; Wang X; He Y; Chen X; Huang Y; Yin W; Zhou Q
J Neuropathol Exp Neurol; 2006 Sep; 65(9):905-13. PubMed ID: 16957584
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of Hsp-27 in astrocytic brain tumors: an immunohistochemical study.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Varakis I
Anticancer Res; 1997; 17(4A):2677-82. PubMed ID: 9252700
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
27. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system.
Bresalier RS; Yan PS; Byrd JC; Lotan R; Raz A
Cancer; 1997 Aug; 80(4):776-87. PubMed ID: 9264362
[TBL] [Abstract][Full Text] [Related]
28. Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors.
Ellert-Miklaszewska A; Grajkowska W; Gabrusiewicz K; Kaminska B; Konarska L
Brain Res; 2007 Mar; 1137(1):161-9. PubMed ID: 17239827
[TBL] [Abstract][Full Text] [Related]
29. Fascin expression in 90 patients with glioblastoma multiforme.
Roma AA; Prayson RA
Ann Diagn Pathol; 2005 Dec; 9(6):307-11. PubMed ID: 16308158
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies.
Torp SH
Clin Neuropathol; 2002; 21(6):252-7. PubMed ID: 12489673
[TBL] [Abstract][Full Text] [Related]
31. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas.
Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L
Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908
[TBL] [Abstract][Full Text] [Related]
32. [Increased amounts of IL-10 mRNA in anaplastic astrocytomas and glioblastoma multiforme].
Huettner C; Paulus W; Roggendorf W
Verh Dtsch Ges Pathol; 1994; 78():418-22. PubMed ID: 7534012
[TBL] [Abstract][Full Text] [Related]
33. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
[TBL] [Abstract][Full Text] [Related]
34. Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin.
Yokota T; Kouno J; Adachi K; Takahashi H; Teramoto A; Matsumoto K; Sugisaki Y; Onda M; Tsunoda T
Acta Neuropathol; 2006 Jan; 111(1):29-38. PubMed ID: 16320026
[TBL] [Abstract][Full Text] [Related]
35. The expression of thyroid hormone receptor isoforms in human astrocytomas.
Hwang SL; Lin CL; Lieu AS; Hwang YF; Howng SL; Hong YR; Chang DS; Lee KS
Surg Neurol; 2008 Dec; 70 Suppl 1():S1:4-8; discussion S1:8. PubMed ID: 18617237
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression.
Cleynen I; Huysmans C; Sasazuki T; Shirasawa S; Van de Ven W; Peeters K
Cancer Res; 2007 May; 67(10):4620-9. PubMed ID: 17510387
[TBL] [Abstract][Full Text] [Related]
37. Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma.
Reeves SA; Chavez-Kappel C; Davis R; Rosenblum M; Israel MA
Cancer Res; 1992 Dec; 52(24):6871-6. PubMed ID: 1333884
[TBL] [Abstract][Full Text] [Related]
38. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of the expression of endothelial-monocyte activating polypeptide II (EMAPII) in the treatment of glioblastoma with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
Yamamoto M; Fukushima T; Ueno Y; Hayashi S; Kimura H; Soma G; Tomonaga M
Anticancer Res; 2000; 20(6A):4081-6. PubMed ID: 11131676
[TBL] [Abstract][Full Text] [Related]
40. Expression and activity of l-isoaspartyl methyltransferase decrease in stage progression of human astrocytic tumors.
Lapointe M; Lanthier J; Moumdjian R; Régina A; Desrosiers RR
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):93-103. PubMed ID: 15857672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]